---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-288468"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2026-06-29T20:15:37+00:00"
generated_at: "2026-06-29T20:17:20.528741+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics closes $3M private placement; warrants could add $6M

## Summary
- Gross proceeds of $3.0M from sale of 4.08M shares/pre-funded warrants + warrants at $0.735/share.
- Net proceeds ~$2.6M; warrants exercisable only after stockholder approval for up to 8.16M additional shares.
- If all warrants exercised for cash, total gross proceeds could reach ~$9.0M.
- H.C. Wainwright acted as placement agent, receiving 7% cash fee and 285,714 placement agent warrants.
- Funds earmarked for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001193125-26-288468
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2026-06-29T20:15:37+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000119312526288468/0001193125-26-288468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000119312526288468/fblg-20260625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-288468
- JSON: https://secwatch.observer/filing/0001193125-26-288468.json
- Plain text: https://secwatch.observer/filing/0001193125-26-288468.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.